Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21 Hold
2
﹤0.01% 589
2025
Q4
$27 Hold
2
﹤0.01% 590
2025
Q3
$32 Hold
2
﹤0.01% 559
2025
Q2
$22 Hold
2
﹤0.01% 504
2025
Q1
$28 Hold
2
﹤0.01% 438
2024
Q4
$45 Hold
2
﹤0.01% 443
2024
Q3
$31 Hold
2
﹤0.01% 446
2024
Q2
$27 Sell
2
-9
-82% -$109 ﹤0.01% 437
2024
Q1
$152 Hold
11
﹤0.01% 453
2023
Q4
$214 Hold
11
﹤0.01% 449
2023
Q3
$169 Hold
11
﹤0.01% 452
2023
Q2
$240 Buy
11
+9
+450% +$245 ﹤0.01% 468
2023
Q1
$58 Hold
2
﹤0.01% 387
2022
Q4
$51 Hold
2
﹤0.01% 374
2022
Q3
$58 Hold
2
﹤0.01% 359
2022
Q2
$51 Buy
+2
New +$58 ﹤0.01% 356

Other funds holding EMBC

PFS Partners's EMBC Position: Q1 2026 in Review

PFS Partners held its Embecta (EMBC) position steady in Q1 2026 at 2 shares worth $21. The position accounts for ﹤0.01% of the portfolio, ranked #589.

PFS Partners first reported a position in EMBC in Q2 2022 and has held it in 16 quarters since. The position peaked at $240 in Q2 2023. 337 funds tracked by Wall St. Rank hold EMBC as of Q1 2026.

  • PFS Partners held 2 shares of Embecta worth $21 as of Q1 2026.
  • PFS Partners left its Embecta share count unchanged in Q1 2026.
  • Embecta made up ﹤0.01% of PFS Partners's portfolio in Q1 2026, its #589 holding.
  • PFS Partners first reported a position in Embecta in Q2 2022 and has held it in 16 quarters since.
  • PFS Partners's Embecta position peaked at $240 in Q2 2023.
  • 337 funds tracked by Wall St. Rank held Embecta as of Q1 2026.

Based on PFS Partners's 13F filing for Q1 2026, filed 9 Apr 2026.